Corient Private Wealth
LMAT icon

Corient Private Wealth’s LeMaitre Vascular LMAT Stock Holding History

Corient Private Wealth’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.46M Buy
25,619
+9,905
+63% +$1.02M ﹤0.01% 1269
2026
Q1 		$1.72M Buy
+15,714
New +$1.5M ﹤0.01% 1346

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Corient Private Wealth's LMAT Position: Q2 2026 in Review

Corient Private Wealth increased its LeMaitre Vascular (LMAT) stake by 63% in Q2 2026, buying an estimated $1.02M and bringing the position to 25,619 shares worth $2.46M. The position accounts for ﹤0.01% of the portfolio, ranked #1269.

Corient Private Wealth first reported a position in LMAT in Q1 2026 and has held it in 2 quarters since. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Corient Private Wealth held 25,619 shares of LeMaitre Vascular worth $2.46M as of Q2 2026.
  • Corient Private Wealth bought 9,905 LeMaitre Vascular shares in Q2 2026, an estimated $1.02M.
  • LeMaitre Vascular made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1269 holding.
  • Corient Private Wealth first reported a position in LeMaitre Vascular in Q1 2026 and has held it in 2 quarters since.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.